N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk
Open Access
- 13 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 25 (11), 1649-1658
- https://doi.org/10.1038/sj.onc.1209374
Abstract
A role for the N-acetyltransferase 2 (NAT2) genetic polymorphism in cancer risk has been the subject of numerous studies. Although comprehensive reviews of the NAT2 acetylation polymorphism have been published elsewhere, the objective of this paper is to briefly highlight some important features of the NAT2 acetylation polymorphism that are not universally accepted to better understand the role of NAT2 polymorphism in carcinogenic risk assessment. NAT2 slow acetylator phenotype(s) infer a consistent and robust increase in urinary bladder cancer risk following exposures to aromatic amine carcinogens. However, identification of specific carcinogens is important as the effect of NAT2 polymorphism on urinary bladder cancer differs dramatically between monoarylamines and diarylamines. Misclassifications of carcinogen exposure and NAT2 genotype/phenotype confound evidence for a real biological effect. Functional understanding of the effects of NAT2 genetic polymorphisms on metabolism and genotoxicity, tissue-specific expression and the elucidation of the molecular mechanisms responsible are critical for the interpretation of previous and future human molecular epidemiology investigations into the role of NAT2 polymorphism on cancer risk. Although associations have been reported for various cancers, this paper focuses on urinary bladder cancer, a cancer in which a role for NAT2 polymorphism was first proposed and for which evidence is accumulating that the effect is biologically significant with important public health implications.Keywords
This publication has 133 references indexed in Scilit:
- The Structure of Arylamine N-acetyltransferase from Mycobacterium smegmatis—An Enzyme which Inactivates the Anti-tubercular Drug, IsoniazidJournal of Molecular Biology, 2002
- 3D Model of Human Arylamine N-Acetyltransferase 2: Structural Basis of the Slow Acetylator Phenotype of the R64Q Variant and Analysis of the Active-Site LoopBiochemical and Biophysical Research Communications, 2002
- POLYMORPHISMS OF N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASE MU AND THETA GENES AS RISK FACTORS OF BLADDER CANCER IN RELATION TO ASTHMA AND TUBERCULOSISJournal of Urology, 2000
- Glutathione S-transferase ?? as a risk factor in bladder tumoursPharmacogenetics, 1996
- Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populationsPharmacogenetics, 1996
- Primary Aromatic Amines from Side-Stream Cigarette Smoke are Common Contaminants of Indoor AirToxicology and Industrial Health, 1993
- The Structure and Characteristics of a Fourth Allele of Polymorphic N-Acetyltransferase Gene Found in the Japanese PopulationBiochemical and Biophysical Research Communications, 1993
- N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cellsBiochemical and Biophysical Research Communications, 1992
- Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cellsCarcinogenesis: Integrative Cancer Research, 1992
- N-Acetylation Phenotype in Bladder CancerHuman Toxicology, 1982